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ABSTRACT 
Verbal memory (VM) has been shown to be impacted in brain tumor (BT) survivors, but 
the nature of VM problems and underlying neuropathology are poorly understood and a long-
term outlook is lacking. Our study examined hippocampus volume (HV) and VM in adult 
survivors of pediatric BT (n=32) and controls (n=48). Results indicate that disruption to a 
maturing brain in childhood is detectable 17 years (mean) after diagnosis, as HV is significantly 
lower in survivors compared to controls. Analysis of the VM scores shows that survivors have 
significantly lower overall immediate recall compared to controls, but learning slope, retention, 
and recognition are not different across the groups. Survivors’ memory profile indicates that 
auditory attention and retrieval difficulties could be contributing to their lower immediate 
recall. For survivors, HV is significantly correlated with delayed free recall but not with other 
VM indices. Implications of these findings are discussed. 
INDEX WORDS: Hippocampus, Verbal memory, Pediatric brain tumor, Survivorship, Long-term 
outcomes,  Neuroimaging 
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1. INTRODUCTION 
Quality of survival has become a justifiable concern for adult survivors of childhood 
brain tumor because of the high survival rate that has been achieved (Ris, 2007). The survival 
rate for childhood brain tumors is estimated to be 70% at 5 years post diagnosis and 4 new 
cases are diagnosed per 100,000 every year (Bleyer, 1999; Legler, Ries, Smith, Warren, 
Heineman, Kaplan, & Linet, 1999). While treatment related advances have led to promising 
survival rates, neurocognitive dysfunction has been shown to be one of the sequelae of 
childhood central nervous system (CNS) cancer. Deficits in a wide range of neuropsychological 
domains have been reported for survivors of childhood brain tumors (Maddrey, Bergeron, 
Lombardo, McDonald, Mulne, Barenberg, & Bowers, 2005; Reimers, Ehrenfels, Mortensen et 
al., 2003). In the past, neurobehavioral late effects in brain tumor patients were assumed to be 
less prevalent than what the evidence currently shows (Ris, 2007).  
1.1 Cognitive Outcomes 
IQ tests have been the most common method used to report the neurocognitive effects 
of brain tumors and their treatment, as IQ tests are well normed and standardized on a large 
sample from the general population (Mulhern, Merchant, Gajjar, Reddick, & Kun, 2004). IQ 
declines of up to 25-30 points have been observed in pediatric brain tumor survivors (Reimers, 
Ehrenfels, Mortensen et al., 2003; Ris, 2007). This finding has been quite consistent in 
longitudinal studies, especially those in which patients were treated with radiotherapy. These 
declines, however, reflect scaled scores. Examination of raw scores reveals significant increase 
over time, which suggests that pediatric survivors are continuing to acquire new information 
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and skills over time, but at a slower rate compared to a neurotypical population (Palmer, 
Goloubeva, Reddick et al., 2001).  
It has been suggested that these declines in IQ scaled scores could be due to deficits in 
underlying memory abilities as learning efficiently and retaining information are critical for 
acquiring new information (Mulhern & Palmer, 2003; Mulhern, Merchant, Gajjar, Reddick, & 
Kun, 2004). Some researchers have shown that pediatric brain tumor survivors have decreased 
verbal memory (Dennis, Spiegler, Hoffman, Hendrick, Humphreys, & Becker, 1991; Ellenberg, 
Liu, Gioia et al. 2009; Winqvist, Vainionpaa, Kokkonen, & Lanning, 2001). Researchers have also 
shown that memory impairment could be contributing to learning disabilities during schooling 
(Gimenez, Junque, Naberhaus et al., 2004). As underlying memory abilities could be responsible 
for rate of information acquisition in survivors, we need to further our understanding of verbal 
memory in adult survivors of pediatric brain tumor. 
Verbal memory is defined as the ability to learn, retain, and recall verbal items or words. 
One study involving survivors of adult brain tumors (Age at testing, M = 36 years) reported that 
free recall of a word list is negatively affected in adults with low grade supratentorial tumors 
treated with radiotherapy (Armstrong, Stern, & Corn, 2001). Another study showed list learning 
and delayed list recall impairment in child survivors of third ventricle tumors, some of whom 
were treated with and some of whom were not treated with radiotherapy (King, Fennell, 
Williams, Algina, Boggs, Crosson, & Leonard, 2004). The authors, however, acknowledged that it 
was unclear whether these impairments were due to poor encoding or poor retrieval. Another 
study involving children with third ventricle tumors (including radiotherapy and non-
radiotherapy patients) reported a retrieval deficit (Micklewright, King, Morris, & Morris, 2007). 
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Specifically, these children were unable to encode new words at the same rate as healthy peers 
and also showed impaired performance on delayed recall. They showed adequate performance 
on delayed recognition and attentional abilities. The same study revealed that children with 
cerebellar tumors, in contrast to third ventricle tumors, had significant auditory attentional 
impairments. Rate of encoding new words for the cerebellar tumor group was similar to healthy 
peers and adequate retrieval was noted. Thus, findings on the nature of verbal memory 
problems that may be faced by brain tumor survivors are mixed and complicated by 
developmental stage and tumor location. Therefore, one of the goals of the current study was 
to clarify the nature of verbal memory deficits in adult survivors of pediatric brain tumor.  
As most research on survivors takes place in the first 5 years following treatment, a 
long-term outlook on memory is lacking. Many previous studies have demonstrated that there 
is a high risk for neurocognitive impairment in survivors of CNS malignancy during childhood. 
Very few studies, however, have examined long-term cognitive sequelae. In two studies of 
pediatric brain tumor survivors, one with a heterogeneous sample of tumors and another with 
only posterior fossa tumors, cognitive dysfunction and significant memory problems were 
reported on average 8-10 years after diagnosis (Lannering, Marky, Lundberg & Olsson, 1990; 
Steinlin, Imfeld, Zulauf, et al., 2003). The dysfunction was present in those treated with and 
without radiotherapy. A review paper on neurobehavioral outcome in pediatric brain tumor 
patients discussed several studies which showed an IQ<80 on average 10 years after diagnosis 
(Ris & Noll, 2004). There were, however, several limitations to the research included in this 
review. Firstly, most of the studies did not objectively test memory and used self-report 
measures. Secondly, the studies discussed were short-term (i.e. survivors were on average 4 
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years or less post-diagnosis) and thus were not able to fully explore long-term sequelae. Only 
one study included in the review showed that neurocognitive impairment extends into 
adulthood (for radiotherapy and non-radiotherapy pediatric survivors). This finding, however, 
was based solely on self-report measures (Ellenberg, Liu, Gioia et al., 2009). Thus, long-term 
memory sequelae in pediatric brain tumor survivors remain largely unexamined in the 
literature.  
When brain tumors occur during childhood the brain maturation is incomplete. 
Therefore, short-term outcomes may not be good indicators of cognitive function during 
adulthood. Moreover, studies examining longer term survivors only investigate IQ or self-
reported cognitive outcomes. Thus, it is unclear how memory develops as survivors of 
childhood brain tumors mature into adulthood. Therefore, studies examining memory 
outcomes in the time period after the first 5 years of diagnosis are needed, with a special 
emphasis on a developmental perspective. A developmental perspective acknowledges that the 
brain and memory systems are still maturing during childhood, at the time when the tumor is 
diagnosed and treated. As such, the diagnosis and treatment of the tumor may be impacting 
the systems that are already in place, as well as the systems that are yet to develop. Therefore, 
in our study we set out to investigate whether pediatric brain tumor survivors experience 
memory impairments as adults using standardized testing methods. This allowed us to address 
the extent and type of deficits that persist in the long-term.  
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1.2 Memory and Hippocampus 
Declarative memory is highly dependent on the integrity of the hippocampus and other 
anatomically related structures (Squire, 1992; Nagel, Palmer, Reddick et al., 2004). Verbal 
memory is a type of declarative memory. A few studies of brain tumor survivors have reported 
memory problems. Thus, it is possible that hippocampal pathology underlies some of the 
memory impairment. Furthermore, recent neuroimaging studies have reported structural 
changes in hippocampal regions, as well as reduced white matter integrity, in childhood brain 
tumor survivors (Dennis, Spiegler, Fitz, & Hoffman, 1991; Mulhern, Merchant, Gajjar, Reddick, 
& Kun, 2004; Nagel, Palmer, Reddick et al., 2004; Van Petten, Plante, Davidson, Kuo, Bajuscak, 
& Glisky, 2004). Even so, the neuropathology underlying cognitive deficits in adult survivors of 
childhood brain tumor is poorly understood. It is unclear whether structural hippocampus and 
white matter changes persist into adulthood, or if they resolve over the course of brain 
development. Thus, extant research begs the question of whether decreased verbal memory in 
survivors is the result of a damaged hippocampus.  
Hippocampal-dependent behavioural tasks are negatively impacted by apoptosis and 
decreased neurogenesis in this region (Nagel et al., 2004). It is well known that the 
hippocampus is primarily responsible for encoding declarative memories (which includes verbal 
memory). Hippocampal pathology in early Alzheimer’s disease has been associated with an 
encoding deficit profile: deficits in both free recall and recognition memory, indicating 
impairment at the level of encoding (Carlesimo & Oscar-Berman, 1992; Fernandez, Weyerts, 
Schrader-Bolsche et al., 1998). In contrast, when memory declines are observed in the context 
of non-hippocampal related pathology (e.g. white matter disease), recognition abilities remain 
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relatively intact but retrieval abilities are damaged (Libon, Bogdanoff, Cloud, Skalina, 
Giovannetti, Gitlin, & Bonavita, 1998; Tierney, Black, Szalai, Snow, Fisher, Nadon, & Chui, 2001). 
This is known as a retrieval deficit profile and is typically seen in older adults in the presence of 
subcortical white matter hyperintensities (Van Petten, Plante, Davidson, Kuo, Bajuscack, & 
Glisky, 2004). 
It follows then that hippocampal abnormalities in adults would lead to a memory profile 
primarily consisting of encoding deficits. In other words, lower hippocampal volume would be 
predictive of impairments on initial learning, recall, and recognition. One study of 30 patients 
with Alzheimer’s disease and ischemic vascular dementia has shown that the size of the 
hippocampus is significantly correlated with the California Verbal Learning Test - II (CVLT-II) 
recognition discriminability index (Libon, Bogdanoff, Cloud, et al., 1998). This study reported 
that higher scores on the CVLT-II recognition discriminability index were associated with a 
larger size of the hippocampal body. Another study involving adolescents with a history of 
premature birth has reported positive correlations between hippocampal gray matter and 
verbal learning and memory (Gimenez, Junque, Narberhaus, et al., 2004). Stereological analysis 
revealed that lower volume of the left posterior hippocampus was associated with a lower level 
of learning. All of these findings indicate that the hippocampus is one of the key structures 
involved in verbal memory, specifically encoding.   
Most of these findings linking the hippocampus to verbal memory, however, emerged 
from research where the hippocampus faced insults during adulthood. The relationship 
between memory functioning and hippocampal volume is controversial among developing 
children (Nagel, Palmer, Reddick et al., 2004). As such, examining the association between 
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hippocampal volume and memory functioning in pediatric brain tumor survivors during 
adulthood (when hippocampal development is complete) should make it possible to 
understand long-term outcomes in the face of early hippocampal insult. Currently, there is 
scant research within the population of adult pediatric brain tumor survivors on the 
hippocampus and its role in verbal memory. It is unclear what deficit patterns emerge in 
adulthood due to disruption of a developing memory system.  
In a population of adult brain tumor survivors, for whom insults to the brain and 
possibly the hippocampus occurred during childhood, one would predict an encoding deficit 
profile. However, there is no current research that tests this prediction. The aforementioned 
research findings, from short-term studies with children and those from adult brain tumors, 
cannot be mapped on to adult survivors of pediatric brain tumors because damage to a 
maturing memory system could lead to different long-term outcomes than damage to an 
already mature system. Therefore, it is important to evaluate whether the prediction of an 
encoding deficit profile in adult survivors of childhood brain tumor holds true.  
1.3 Hippocampal Development 
Structural development of the cortex rather than sub-cortical regions is the focus of 
most imaging investigations of the developing brain (Giedd et all, 1999; Gogtay et al., 2004). 
Temporal cortex white matter integrity has been shown to increase across age groups in a 
study of healthy older children and adolescents (Mabbot, Rovet, Noseworthy, Lou Smith, & 
Rockel, 2009). Likewise, the hippocampus and other medial temporal lobe gray matter 
structures have been shown to increase in volume during childhood and adolescence. One 
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study has shown that the volume of the hippocampal formation increases sharply in typically 
developing children until they reach the age of 2, after which point the volume increase 
becomes much slower (Utsunomiya, Takano, Okazaki, & Mitsudome, 1999). Normal 
hippocampal development, however, continues into early adulthood (Benes, Turtle, Khan, & 
Farol, 1994). Thus, some of the aforementioned memory impairments in childhood brain tumor 
survivors could be the consequence of a hippocampus that is not maturing as expected, due to 
injury during early developmental stages. Therefore, in our study we set out to extend previous 
neuroimaging investigations by specifically examining the long-term developmental outcomes 
of hippocampal structure and function. 
With regard to structure, function, and the potential for plasticity, the hippocampus is 
unique (Williamson & Bilbo, 2013). However, the same reasons that make the hippocampus 
unique also make it particularly vulnerable to insult. Studies have shown that the hippocampus 
is rendered more vulnerable to damage due to brain-derived neurotropic factor (BDNF) 
plasticity in the hippocampal formation (Murray & Holmes, 2011). Neuron survival and 
apoptosis is modulated by BDNF-associated signalling, implicating it in developmental 
processes. Another underlying mechanism for the coexistence of plasticity and vulnerability 
within the hippocampus are immune signalling molecules such as chemokines (Williamson & 
Bilbo, 2013). Consistent with these findings, injuries and CNS disorders such as ischemia and 
Alzheimer’s disease have been shown to have a remarkable negative impact on the 
hippocampus (Franklin et al., 2003; Araujo & Lapchak, 1994). Given these unique vulnerabilities 
of the hippocampus, it is important to examine how it is impacted in adult survivors of 
childhood brain tumor.  
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Atypical hippocampal development, as measured by neuroimaging, has been evidenced 
in at least one brain tumor research study. In a longitudinal study of 25 children newly 
diagnosed with medulloblastoma, the researchers examined hippocampal development for up 
to 5 years after diagnosis (Nagel, Palmer, Reddick et al., 2004). The children were on average 
8.27 years old at the time of diagnosis and the time between diagnosis and initial examination 
was 0.31 years (mean). The study showed, over the course of 6 magnetic resonance imaging 
scans, that hippocampal volume declined in these children until 2 years post-diagnosis, after 
which the normal positive growth pattern resumed. These findings, however, should be 
interpreted with caution due to a number of limitations. Firstly, as study tracked development 
for 5 years it cannot address the question of whether initial declines in hippocampal volume 
were ultimately compensated for by return to normal growth in later life. Secondly, the study 
did not have a control group to compare how the hippocampal volume changed over a 2-year 
time span in healthy children of the same age. Furthermore, the study did not include any brain 
tumor patients who had not received radiation therapy. This makes it difficult to conclude 
whether atypical hippocampal development is associated with brain tumor and surgical factors 
or treatment factors. 
In a study reporting atypical hippocampal development in pediatric brain tumor (Nagel, 
Palmer, Reddick et al., 2004), volume loss occurred predominantly in the posterior regions of 
the hippocampus. Examination of radiation dosimetry mapping for a sample case showed that 
posterior hippocampal regions were closer to higher-dose radiation fields. This finding is 
important in the context of verbal memory impairment because a study using functional 
magnetic resonance imaging has shown that the posterior part of the hippocampus is engaged 
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in verbal encoding (Fernandez, Weyerts, Schrader-Botsche et al., 1998). In this study, thirteen 
healthy volunteers performed a word list learning paradigm. For eleven of these volunteers, 
there was a significant correlation between voxel clusters in the posterior part of the 
hippocampus (images acquired during encoding) and subsequently recalled words. Together 
these studies indicate that a linkage between hippocampus volume (especially in the posterior 
part of the hippocampus) and encoding of verbal material potentially exists.  
1.4 Current Study 
In the current study, hippocampal volume was measured and verbal memory processes 
were tested in a large sample (n=38) of long-term survivors. The sample of survivors, who are 
now adults, were diagnosed and treated for brain tumors when they were children. We used 
FMRIB’s Integrated Registration and Segmentation Tool (FIRST) (Patenaude, Smith, Kennedy, & 
Jenkinson, 2011) and the California Verbal Learning Test – Second Edition (CVLT-II; Delis, 
Kramer, Kaplan, & Ober, 2000). FIRST has been successfully used to obtain total hippocampal 
volume by other published empirical studies. In addition, the CVLT-II is a well validated measure 
widely used in clinical and research based neuropsychological assessments (Delis, Kramer, 
Kaplan, & Ober, 2000; Hubley, 2004). The CVLT-II is a short, word-list based, individually 
administered assessment tool that allows for the measurement of multiple components of 
memory: learning, retention, retrieval and recognition. The CVLT-II has been shown to predict 
residual brain damage in various psychiatric and neurological populations (Alexander, Stuss, & 
Fansabedian, 2003; Delis, Kramer, Kaplan, & Ober, 2000). Thus, it would serve our study well. 
The current study is the first analysis of hippocampus volume and verbal memory processes in a 
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unique sample of brain tumor survivors, who are many years past their diagnosis and 
treatment. This unique data set allowed us to interpret results from a developmental 
perspective.  
We chose to combine the group of survivors who had received radiation therapy with 
the group of survivors who had not for three reasons: (1) it is possible to have memory deficits 
even in the absence of radiation therapy, as shown by some of the literature (see Ellenberg, Liu, 
Gioia, et al., 2009; King, Fennell, Williams, et al., 2004; Lannering, Marky, Lundberg, & Olsson, 
1990; Micklewright, King, Morris, & Morris, 2007; Steinlin, Imfeld, Zulauf, et al., 2003); (2) it is 
important to examine non-radiotherapy survivors as hippocampus development could also be 
affected by the tumor or by brain surgery; (3) the sample size of the sub-sample of survivors 
who had not received radiation was small (n=13). 
1.5 Radiation 
There is evidence for radiation leading to pathological processes in the hippocampus 
from animal models. This further necessitates the study of this structure in brain tumor 
survivors. A review paper on radiation-induced brain injury notes several hippocampal changes, 
including neuro-inflammation and ablation of neurogenesis, in pediatric and young adult rodent 
brains that have been irradiated (Greene-Schloesser, Robbins, Peiffer, Shaw, Wheeler, & Chan, 
2012). In studies of molecular pathways, alterations in neuronal function of the hippocampus 
have also been noted after radiation (Greene-Schloesser, Moore, & Robbins, 2013). One 
mechanism by which radiation therapy leads to these pathological processes is through 
alterations in cerebrovasculature (Monje, Mizumatsu, Fike, & Palmer, 2002; Monje & Palmer, 
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2003). Ischemic injury in hippocampal regions and white matter is also linked to radiation 
therapy (Tsuruda, Kortman, Bradley, Wheeler, Van Dalsem, & Bradley, 1987; Abayomi, 1996).  
Moreover, hippocampal volume has been linked to cranial radiation for medulloblastoma 
survivors in a dose-dependent way (Riggs, Schoenhoff, Liu, Wang, Dockstader, Bouffet, 
Mabbott, 2013). Riggs et al. found significant group differences when comparing children 
treated with standard dose radiation to those treated with reduced dose and healthy controls. 
As 59% of the adult pediatric brain tumor survivors in our study had received radiation therapy, 
there was a potential for radiation induced pathological processes in the hippocampus of those 
survivors. The absence of detailed radiation therapy specific information for our sample (i.e., 
whole brain vs. focal, dosage, posterior fossa boost, dosimetry) precluded precise examination 
of radiation effects. However, we did explore the role of radiation therapy by examining effect 
sizes for sample sub-groups. 
1.6 Specific Aims and Hypotheses 
1.6.1 Aim 1  
Structural changes in the hippocampus have been reported in child survivors of brain 
tumor.  Therefore, the first aim of our study was to compare the hippocampal volume of 
survivors to controls. Also, as the whole brain is subjected to many of the diagnostic and 
treatment related aspects of having a brain tumor we examined a control structure to help us 
determine if the hippocampus is structurally special or if there is a global impact to the brain. 
Hypothesis 1. Survivors will show lower hippocampal volume compared to healthy 
 controls. 
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1.6.2 Aim 2 
Adult survivors of childhood brain tumor may have received insults to hippocampal 
regions and white matter development. Thus, it was likely that they would demonstrate verbal 
memory problems with regard to both encoding and retrieval. The second aim was to evaluate 
whether survivors differ from healthy controls on various verbal memory indices. 
Hypothesis 2a. Survivors’ immediate free recall performance compared to healthy 
 controls will be lower. Evaluation of their learning characteristics will reveal lower 
 auditory attention compared to controls but their learning slope will be comparable to 
 controls.  
Hypothesis 2b. Survivors will show lower delayed free recall compared to controls. 
 Evaluation of their delayed free recall in the context of other memory performance 
 scores will show problems with initial learning and with retention.  
Hypothesis 2c. Delayed recognition memory will be lower compared to controls, due to 
 problems with initial learning. 
1.6.3 Aim 3 
Another aim was to examine the correlation of hippocampus size and verbal memory 
indices for survivors. The size of the hippocampus has been reported to be correlated with 
various verbal memory indices in other patient populations. However, in neurologically intact 
adults the “bigger is better” account of regional structure-function relationships may be too 
simplistic (Van Petten et al., 2004). Therefore, we chose to examine the hippocampus – verbal 
memory association in the survivor group alone. Furthermore, we decided a priori that we 
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would proceed with Aim 3 only if the findings of Aim 1 were significant. In order to increase 
model specificity, we also examined the associations between a control region and verbal 
memory and the hippocampus and a control task.  
2. METHODS 
2.1 Participants 
The sample of participants (N=80) consisted of long-term survivors of childhood brain 
tumors (n=32) and healthy controls (n=48). All data emerged from an American Cancer Society 
study (grant # RSGPB-CPPB-114044, PI: Tricia Z. King) of adult survivors of pediatric brain tumor. 
Survivors were recruited through large mailings: (1) to individuals who participated, as children, 
in a longitudinal study at the time of diagnosis, (2) through the Brain Tumor Foundation of 
Georgia, (3) to survivors treated at local hospitals over 10 years ago. Survivors were on average 
17.04 years past their diagnosis. Healthy controls in the existing data set were recruited 
through the undergraduate Psychology participant pool at Georgia State University (GSU), the 
Joint GSU/GA Tech Center for Advanced Brain Imaging (CABI), friends of survivors, and 
community fliers.  
Participants were considered ineligible and excluded from the current study if they did 
not indicate fluency in English, met diagnostic criteria for a pervasive developmental disorder, 
or had experienced any other significant neurological insult (e.g. traumatic brain injury). They 
were also considered ineligible if they did not pass the hearing screening. For healthy controls, 
there were additional exclusion criteria based on a Structured Clinical Interview of the DSM-IV 
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Axis I Disorders (SCID).  Participants were excluded for current Major Depressive Disorder, 
substance use, or psychotic disorder. 
All participants signed informed consent forms and the study protocol was approved by 
Georgia State University (GSU IRB # H03177) and Joint GSU/GA Tech Center for Advanced Brain 
Imaging (CABI) (IRB # H09157) Institutional Review Boards. All participants responded to a 
demographic questionnaire and were administered a hearing test, a structured clinical 
interview, a verbal memory test, and a fine-motor test among other measures. Survivors in the 
study were also interviewed to gather information about medical variables such as age at 
diagnosis and presence of radiation. The entire sample of participants also underwent 
neuroimaging.  
2.2 Measures 
2.2.1 Hearing screening  
The hearing screening administered was a standard tone task using an audiometer. 
Participants wore earphones and tones with varying levels of frequency and wavelength were 
played. As the verbal memory task that was administered was auditory in nature it was 
important to ensure that participants were able to hear within the normal range of sounds. This 
was especially important for the brain tumor survivors as many individuals in this population 
endure damage to their hearing as a side-effect of treatments. Participants were excluded if 
they evidenced difficulties on screening and understanding conversational interactions during 
testing.  
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2.2.2 Psychiatric screening 
In order to screen for psychiatric disorders, trained psychology graduate students 
administered the Structured Clinical Interview of DSM-IV Axis I Disorders (SCID) - Research 
Version. The SCID is a semi-structured interview designed to assess major psychiatric disorders 
based on DSM-IV criteria. This allowed researchers to diagnose psychiatric disorders that were 
part of the study’s exclusion criteria for the healthy comparison group. Survivors were never 
excluded, except in the case of pervasive developmental disorders (n=1). Of the survivors 
included, two met criteria for Dysthymia, of which one also met criteria for Generalized Anxiety 
Disorder. One survivor met criteria for Alcohol Abuse and Dependence in Full Remission.  
2.2.3 California Verbal Learning Test – Second Edition (CVLT-II) 
The CVLT-II (Delis, Kramer, Kaplan, & Ober, 2000) assesses various aspects of verbal 
memory. The CVLT-II has adequate reliability and validity overall, with internal consistency 
estimates usually in the range of .80 or higher (Delis et al., 2000; Hubley 2004). During the test, 
the experimenter verbally presents a list of 16 words and asks the participant to immediately 
recall as many items as they can. This is done for 5 consecutive trials. The CVLT-II generates 
multiple memory performance indices, a few of which were selected for the current study:  
(1) The Trials 1-5 Total Correct score is a global measure of immediate free recall 
 performance and consists of the total number of items recalled during the initial 
 learning trials.  
(2) The Trial 1 score is the number of items learned and recalled after the first 
 presentation of the word list and is thought to indicate auditory attention.  
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(3) The Trial 5 score is the number of items learned and recalled after repeated 
 presentation of the word list.  
(4) The CVLT-II also assesses Learning Slope, which reflects the average number of new 
 words acquired and recalled per trial.  
(5) Following a delay period of 20 minutes after the initial learning trials, participants are 
 again asked to recall as many items as possible. The Long Delay Free Recall (LDFR) score 
 indicates the total number of items recalled after this 20 minute delay. LDFR provides an 
 estimate of the amount of verbal information a person is able to retain and retrieve.  
(6) The CVLT-II also assesses delayed recognition memory through correctly identified 
 items (recognition hits) in a forced-choice yes or no test, presented at the end of the 
 test. This forced-choice test consists of all 16 target words from the original list, in 
 addition to other semantically related and unrelated words. Comparing the recognition 
 hits to false positives (intrusions) yields the Recognition Discriminability index.  
2.2.4 Grooved Pegboard Test 
The Grooved Pegboard is a test of fine motor speed and manipulative dexterity. It is a 
commonly used measure of skilled motor speed in several neuropsychological batteries (Ruff & 
Parker, 1993). The task requires the participant to insert keyhole-shaped pegs into similarly 
shaped holes in a pegboard, using one hand at a time. The pegs, which have an edge along one 
side, must be matched to the holes. Participants are asked to perform this task as quickly as 
possible without making mistakes. The score obtained is the time required to complete the task 
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with the dominant hand. The norms used for the scores in studies were from Ruff & Parker 
(1993).  
2.2.5 Neuroimaging parameters 
A Siemens Trio 3T scanner with a standard head coil for radiofrequency transmission 
was used to collect all images. Participants were outfitted with protective earplugs to reduce 
scanner noise. We acquired high-resolution (1.0 mm x 1.0 mm x 1.0 mm) T1-weighted 
structural images of the brain by collecting 176 contiguous (i.e. no gap and sharing a common 
border) sagittal slices. A 3D magnetization prepared rapid gradient echo imaging (3D MPRAGE) 
sequence was used with the following parameters: acquisition matrix = 256 x 256, repetition 
time (TR) = 2250ms, echo time (TE) = 3.98ms, field of view (FOV) = 256 mm, slice thickness = 1.0 
mm, flip angle = 9o.  
2.2.6 Hippocampal volume 
Segmentation and volumetric analysis of the hippocampus was performed with FMRIB’s 
Integrated Registration and Segmentation Tool (FIRST) (Patenaude, Smith, Kennedy, & 
Jenkinson, 2011). FIRST is a model-based registration and segmentation tool in FSL 4.0 (Smith, 
Jenkinson, Woolrich, et al., 2004). The shape and appearance models used in FIRST are 
constructed from manually segmented images provided by the Center for Morphometric 
Analysis (CMA), MGH, Boston. During registration, the input 3D T1 image data were 
transformed to the MNI 152 standard space by means of affine transformations based on 12 
degrees of freedom. After registration, a sub-cortical mask was applied to locate the 
hippocampus, followed by segmentation based on shape models and voxel intensities. The 
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hippocampus included the dentate gyrus, the ammonic subfields (CA1–4), the prosubiculum, 
and the subiculum and did not include the fimbria / fornix behind the posterior commissure. 
Hippocampal segmentations were visually checked for errors, and no errors were noted. The 
volume of each participant’s left and right hippocampus was measured in mm3, and the sum of 
these two values yielded Total Hippocampal Volume values to be used in all subsequent 
analyses. See Figures 2.1 & 2.2 for a sample FIRST segmentation of the left and right 
hippocampus. 
 
Figure 2.1 Sample FIRST segmentation of the hippocampus 
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Figure 2.2 3D view of sample FIRST segmentation of the hippocampus and putamen 
2.2.7 Putamen volume 
We acquired putamen volumes using the same methods and software as that used to 
obtain hippocampal volume. The putamen is traditionally not thought to have the same 
metabolic needs as the hippocampus and also not thought to be involved in explicit (i.e. 
declarative) verbal memory. While it would be ideal to use total brain volume as a control 
measure, obtaining total brain volumes for survivors is problematic. Many of the brain images 
of survivors have artefacts at the site of the surgery and/or in the region of shunts, making it 
problematic to obtain tissue volumes for those regions. Given that the putamen, like the 
hippocampus, is a subcortical structure we were able to obtain tissue volumes for the entire 
sample of survivors. See Figures 2.2 & 2.3 for a sample FIRST segmentation of the left and right 
putamen. 
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Figure 2.3 Sample FIRST segmentation of the putamen 
2.3 Procedure 
All participants were tested individually in the Psychology Clinic at GSU or GSU/GA Tech 
Joint Center for Advanced Brain Imaging. Testing took place over two visits; the first one lasting 
approximately 5 hours and the second one lasting approximately 2 hours. At the first visit, 
trained psychology graduate students, under the supervision of a licensed clinician 
administered a medical and developmental history interview, the SCID, self-report paper-and-
pencil questionnaires, and the CVLT-II as part of a larger battery of cognitive tests. The larger 
battery was designed such that the participant’s memory during the 20-minute time delay 
between the Learning and LDFR trials would not be taxed. Also, the CVLT-II was administered 
during the first 30 minutes of the larger battery so fatigue effects were not of concern. The 
examiner also checked hearing and mental status of the participant. Course credit was given to 
the undergraduate control participants as per GSU guidelines. The researchers compensated 
adult brain tumor survivors and community controls with $50. At the second visit, brain imaging 
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took place in an MRI scanner at the GSU/GATech Joint Center for Advanced Brain Imaging, 
Atlanta. A trained MRI technician operated the MRI scanner. All participants received $50 
compensation for their time and travel at the completion of the second visit. 
2.4 Design  
All analyses were conducted using SPSS 17. p-values less than .05 were considered 
statistically significant.  
2.4.1 Test of Data Assumptions 
Proposed data analyses for each of the aims involved a number of steps. As part of 
preliminary analyses, each of the CVLT indices to be used in the current study, measurements 
of hippocampal volume, and of putamen volume were examined for extreme values, 
assumptions of normality, homogeneity of variance, heteroskedasticity, non-independence of 
residuals, normality of residuals, and absence of specification error where appropriate.  
2.4.2 Potential Confounds  
A confound was defined as a variable that was both significantly different between 
groups and correlated with outcome. As two of the aims of our study are based on comparing 
groups, demonstrating group equivalence on relevant demographic variables and identifying 
confounding variables was important. Demographic variables that could act as potential 
confounds, such as gender, age at testing, level of education, and ethnicity, were compared 
across the two groups (survivors vs. controls). Independent samples t-tests were used for 
continuous variables (i.e. age and education). Chi-square tests of independence were used for 
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categorical variables (i.e. gender and ethnicity). We also obtained Pearson bivariate correlations 
for the demographic variables and outcomes of interest. If a variable emerged as significantly 
different between groups and had a significant correlation with the dependent variable being 
examined then it was considered a potential confounding variable.  
2.4.3 Potential Covariates  
Omission of potential covariates that should theoretically be included in a model leads 
to potential bias in the statistical estimates of population parameters (Cohen, Cohen, West, & 
Aiken, 2003). In order to obtain unbiased estimates of the true values in the population it is a 
good idea to estimate a model with these variables included. Even though inclusion of 
covariates in a model reduces degrees of freedom, and thus seemingly power, it actually 
increases precision of the model if the covariates are well-chosen (Cohen, Cohen, West, & 
Aiken, 2003). A well-chosen covariate is a variable that is related to the outcome but unrelated 
to the independent variable and it increases precision by reducing standard error. A reduction 
in standard error is possible because a good covariate increases the amount of variance in the 
outcome explained by the independent variable (without increasing the amount of variance 
explained in each independent variable by all other covariate variables).  
Thus, in order to reduce potential bias in our statistical procedures we used a 
demographic variable as a covariate if that demographic variable was not significantly different 
between the groups but emerged as significantly correlated with the dependent variable. We 
determined covariates separately for each aim, contingent upon the dependent variable of 
interest for the specific analysis of an aim.  
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2.4.4 Survivor-specific Diagnostic & Treatment Variables 
There are many neurobiological treatment variables that are heterogeneous in our 
sample of survivors, such as tumor location, tumor type, presence of radiation, chemotherapy, 
presence of hydrocephalus (see Reimers, Ehrenfels, Mortensen et al., 2003; Scott, Fletcher, & 
Brookshire, 1998) that could potentially impact the outcomes of interest.  Our sample was 
thoroughly described with regard to these neurological variables. As they are known to be 
associated with poor outcomes, we explored their impact on our outcomes, where possible. 
The subsequent steps of specific data analyses for each aim were different and are outlined 
separately. 
2.4.5 Aim 1: Is hippocampal volume lower in survivors compared to controls?  
In order to evaluate whether survivors differ from healthy controls in terms of 
hippocampal volume, we used a one-way between-groups analysis of variance. The 
independent variable was the group (survivors, controls), and the dependent variable consisted 
of measurements of hippocampal volume obtained during the study. In order to increase model 
specificity (i.e. are volume reductions unique to the hippocampus compared to other 
structures), we also examined volumes of the putamen for the two groups. 
2.4.6 Aim 2: Comparing survivors and controls on verbal memory indices  
In order to evaluate whether survivors differ from demographically matched healthy 
controls on verbal memory indices, we conducted separate analyses using CVLT-II data. First, 
we compared survivors and controls on Trials 1-5 Total T score. We decided that if a significant 
difference was found with this index we would evaluate learning strategies. Evaluating learning 
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strategies consisted of (a) examining whether the Trial 5 z-score was significantly different 
between groups after controlling for the Trial 1 z-score and (b) comparing the Learning Slope z-
score. Second, we evaluated whether the LDFR z-score was affected. We decided that if 
survivors had a significantly lower score than controls on this index then we would examine 
whether it is initial learning or retention that is impacting this score. In order to do so, we 
compared survivors and controls on (a) the LDFR z-score after controlling for the Trial 5 z-score 
and (b) the change in number of words from Trial 5 to LDFR. Third, we compared survivors and 
controls with regard to their Recognition Discriminability Index z scores.  
2.4.7 Aim 3: Hippocampus volume correlations with verbal memory indices in survivors  
In order to examine if total hippocampal volume is associated with various verbal 
memory indices, we used correlation analyses. Specifically, one-tailed Pearson bivariate 
correlations were obtained for hippocampal volume with each of the various verbal memory 
indices. We examined correlations between volume and verbal memory outcomes in the group 
of survivors alone, separately from controls. We did this because in neurologically intact adults 
the “bigger is better” account of regional structure-function relationships may be too simplistic 
(Van Petten et al., 2004), as size reveals little about relative proportions of neurons and 
astrocytes, synaptic densities, ratios of excitatory to inhibitory synapses, patterns of synaptic 
connectivity, and numbers of receptors for various transmitter substances. However, in 
samples with neuropathology, below-normal volumes have been associated with cognitive 
deficits and the “bigger is better” account may be useful (Van Petten et al., 2004). Therefore, 
we had decided a priori that Aim 3 would be contingent upon significant findings in Aim 1. 
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Specifically, if survivors were not significantly lower than controls with regard to hippocampal 
volume then we would not conduct the analyses planned for Aim 3.  
Furthermore, if the correlation analyses were carried out, we needed to increase 
confidence that any findings reported were related specifically to the hippocampus. Therefore, 
we also conducted all of the correlational analyses with a control structure – the putamen. 
Examination of correlations across the structure of interest (hippocampus) and a control 
structure (putamen) would help us determine whether global brain changes or local 
hippocampal related changes are affecting verbal memory outcomes. Similarly, we also 
included a control task – Grooved Pegboard Test – that involves fine-motor dexterity skills and 
should theoretically be unrelated to hippocampal volume as part of these correlational 
analyses.  
3. RESULTS 
3.1 Extreme Values 
As part of the preliminary data analyses, 5 outliers (>3 standard deviations from mean) 
were identified that were considered extreme: one control on the total hippocampal volume 
measurements (10,641 mm3), one control on the CVLT-II recognition scores (z= -3), and two 
survivors and one control on the Grooved Pegboard Test (z= -6.19, -9.31, -3 respectively). Three 
of these values were assigned a raw score that was one unit larger or smaller than the next 
most extreme score in the distribution (see Tabachnick & Fidell, 2001). Two of these values (z= -
6.19, -9.31), both from the Grooved Pegboard Test, were excluded from all further analyses. 
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3.2 Potential Confounds 
Demographic characteristics and mean scores on the variables of interest are presented 
in Table 3.1. Pearson chi-square tests for independence with Yates continuity correction 
indicated no significant association between gender and group χ2 (1, n=80) = .002, p = .96 and 
no significant relation between ethnicity and group χ2 (2, n=75) = 4.09, p = .13. Thus, gender 
and ethnicity distributions were equivalent between the two groups. Furthermore, 
independent samples t-tests revealed that participants in the control and survivor groups were 
equivalent (p > .05) on level of education but significantly different (p<.001) on age (see Table 
3.1). However, when we conducted bivariate correlations age was not significantly correlated 
with hippocampal volume or any of the CVLT-II indices, except recognition (See Table 3.2). 
Thus, there were no demographic confounds that needed to be controlled for in subsequent 
analyses, except analyses involving recognition.  
Table 3.1 Comparison of demographic variables 
Demographic Variables Survivors (n=32) Controls (n=48) 
Female (n, %) 17 (53%) 27 (56%) 
Education (mean ± SD) 13.38 ± 1.68 13.88 ± 1.20 
Age at testing (mean ± SD)* 25.15 ± 4.52 21.41 ± 3.90 
   Range 17-36 18-41 
Ethnicity (n, %)   
   Caucasian 22 (71%) 21 (48%) 
   African-American 6 (19%) 14 (32%) 
   Other 3 (10%) 9 (21%) 
Note. *Significantly different between groups at p=.05 
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Table 3.2 Pearson bivariate correlations of demographic variables with outcomes of interest 
 Gender Education Age at Testing Ethnicity 
Hippocampal Volume -.40* .32* -.09 -.04 
Putamen Volume -.26* .15 -.22 -.02 
CVLT-II     
   Trials 1-5 Total T Score -.18 .21 -.21 -.01 
   List A Trial 1 z-score -.31* .04 -.34* -.05 
   List A Trial 5 z-score -.23* .16 -.16 .002 
   Learning Slope z-score -.07 .16 .18 .06 
   Long Delay Free Recall z -.03 .22 -.20 -.05 
   Recognition Discrimin. .04 .33* -.24* .03 
Grooved pegboard -.26* -.17 -.27* .03 
Note. * Significant at p=.05 
3.3 Potential Covariates  
We also conducted bivariate correlations for the demographic variables with 
hippocampal volume, CVLT-II indices, putamen volume, and grooved-pegboard scores (see 
Table 3.2) for the whole sample in order to identify covariates for Aim 1 and Aim 2. The 
covariates that are described in the subsequent analyses are not confounding variables because 
they are not significantly different between the survivor and control group. 
It was found that gender (r= -.40, p<.001) and level of education (r=.32, p=.004) were 
significantly correlated with hippocampal volume, with females and those with lower education 
having lower volumes. Therefore, we used gender and education as covariates in the analysis of 
the hippocampus in Aim 1. No significant correlation was identified between ethnicity or age 
and hippocampal volume (p > .05). Also, gender was significantly correlated with putamen 
volume (r= -.26, p=.02), with females having lower volumes. Therefore, we used gender as a 
covariate in the analysis of the putamen in Aim 1. No significant correlation was identified 
between age, education or ethnicity and putamen volume (p>.05). 
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No significant correlations were identified between gender, ethnicity, level of education, 
age and all CVLT-II indices (p>.05), except Recognition Discriminability. A significant correlation 
was identified between level of education and Recognition Discriminability (r=.33, p<.01), as 
well as age and Recognition Discriminability (r= -.24, p=.03). We did not use both education and 
age as covariates for Recognition Discriminability because they were also significantly 
correlated with each other (r=.26, p=.02). Instead, we chose to use participants’ education level 
alone as a covariate. We did this because unlike age it was not a confound, and thus 
uncorrelated to the independent variable – making it a better covariate statistically. We did not 
use any demographic covariates in analyses involving other CVLT-II indices.  
3.4 Survivor-specific Diagnostic & Treatment Variables 
There were many neurobiological (e.g. tumor type) and treatment (e.g. presence of 
radiation) variables that were heterogeneous in our sample of survivors. Characteristics and 
mean scores on these variables are presented in Table 3.3. These variables were not included as 
covariates in any of the analyses due to limited sample size. However, within the survivor 
group, we explored whether some of these variables were associated with reduced 
hippocampal volume. 
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Table 3.3 Survivor-specific Variables 
Diagnostic & Treatment Variables Survivors (n=32) 
Years post diagnosis (mean ± SD) 
 Range 
17.04 ± 1.08 
5-28 
 Median 18.45 
Age at diagnosis (mean ± SD) 
 Range 
7.84 ± .84 
1-19 
 Median 8.50 
Tumor location (n, %)  
   Posterior fossa 16 (50%) 
   Pituitary 4 (13%) 
   Frontal lobe 2 (6%) 
   Parietal lobe 2 (6%) 
   Occipital lobe 1 (3%) 
   Temporal lobe 1 (3%) 
   3rd ventricle 1 (3%) 
   Brainstem  1 (3%) 
   Unknown 4 (13%) 
Tumor type (n, %)  
   Medulloblastoma 11 (34%) 
   Craniopharyngioma 6 (19%) 
   Astrocytoma/Glioma 10 (31%) 
   Other (PNET, Astroteratoma, Meningioma,    
Mixed germ cell, Choroid plexus papilloma) 
5 (16%) 
Radiation (n, %) 19 (59%) 
Chemotherapy (n, %) 14 (44%) 
Hydrocephalus (n, %) 14 (44%) 
Seizure disorder (n, %) 8 (25%) 
Hormone deficiency (n, %) 16 (50%) 
3.5 Aim 1  
A one-way between-groups analysis of covariance was conducted to compare the 
hippocampal volume of survivors and controls. The independent variable was group (survivors, 
controls), and the dependent variable was measurements of hippocampal volume. Participants’ 
sex (r= -.40, p<.01) and education level (r=.32, p<.001) were used as covariates in this analysis 
because they were each significantly correlated with hippocampal volume (see Table 3.2). The 
use of well-chosen covariates can help reduce error and increase precision when examining 
group differences.  
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Preliminary checks were conducted to ensure that there was no violation of the 
assumptions of normality, linearity, homogeneity of variances, homogeneity of regression 
slopes, and reliable measurement of the covariates. All of these assumptions were acceptable. 
After adjusting for sex and education level, there was a significant difference (F (1,76)=5.34, 
p=.02) between the two groups (see Table 3.4 & Figure 3.1)  on measured hippocampal volume, 
with a medium effect size (partial η2=.07). Also, there was a strong association between sex and 
hippocampal volume (partial η2=.26) and education level and hippocampal volume (partial 
η2=.17), with males and those with higher education having higher volumes. 
We conducted similar analyses using total putamen volumes, in order to test the 
specificity of our hypothesis with regard to the hippocampus. After adjusting for sex, there was 
a significant difference (F (1,79)=15.14, p<.001) between the two groups (see Table 3.4 & Figure 
3.1)  on measured putamen volume, with a large effect size (partial η2=.16). 
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Table 3.4 Comparison of outcome variables for the two groups 
 Survivors (n=32) 
Mean ± SD 
Controls (n=48) 
Mean ± SD 
Total Hippocampal Volume* 
 Unadjusted  
 Adjusted (Mean ± SE)† 
 
7411.31±914.38 
7464.73±129.43 
 
7888.60±833.88 
7852.99±105.35 
Total Putamen Volume* 
 Unadjusted 
 Adjusted (Mean ± SE)† 
 
9626.53±1341.02 
9613.35±203.80 
 
10628.60±1094.57 
10637.39±166.39 
CVLT-II   
   Trials 1-5 Total T score* 
 Number Impaired (%) 
46.88±11.70 
5 (15%) 
52.21±11.08 
3 (6%) 
   List A Trial 1 z-score -.80±.74 -.10±1.08 
   List A Trial 5 z-score -.59±1.36 -.05±1.12 
   Learning Slope z-score .05±.95 -.24±.99 
   Long Delay Free Recall z-score 
 Number Impaired (%) 
-.55±1.25 
7 (22%) 
-.05±1.08 
6 (13%) 
   Recognition Discriminability Index z-score 
 Unadjusted 
 Adjusted (Mean ± SE) 
 Number Impaired (%) 
 
-.28±1.05 
.04 ± .14 
6 (19%) 
 
.08±.97 
-.22 ± .17 
6 (13%) 
Note. *Significantly different between groups at p=.05. †Adjusted means for hippocampal 
volume = means adjusted by sex and education as part of the ANCOVA. Adjusted means for 
putamen volume = means adjusted by sex as part of the ANCOVA. 
 
 
Figure 3.1 Total hippocampal & putamen volumes 
Note. *Indicates significant difference at p=.05. Error bars represent standard error. 
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3.6 Aim 2  
In order to explore the impact of group (survivors vs. controls) on the chosen verbal 
memory performance indices, we conducted one-way analysis of variance. All CVLT-II indices 
used as dependent variables in these analyses, unless otherwise indicated, consisted of 
standardized scores derived from the CVLT-II normative sample. There was no violation of the 
assumptions of normality and homogeneity of variances for all scores, except Recognition 
Discriminability. The assumption of normality was violated for the Recognition Discriminability 
index scores. The distribution of the sample was negatively skewed. We transformed the 
variable to attempt to correct for this violation using a square root and a logarithmic 
transformation. However, the transformations did not help normalize the distribution and did 
not impact the relations of interest. Therefore, the untransformed variable was used in all 
subsequent analyses.   
3.6.1 2a Immediate free recall performance 
A one-way between groups analysis of variance (ANOVA) showed that there was a 
statistically significant difference (F (1,78)=4.26, p=.04) in Trials 1-5 Total T scores for the two 
groups (see Table 3.4 & Figure 3.2). On average, survivors scored lower than controls. The 
actual difference in mean scores between the groups was a medium effect size of .05, 
calculated using partial η2. Furthermore, the performance of 5 survivors (15%) and 3 controls 
(6%) was in the clinically impaired range (i.e. T≤35). A Pearson chi-square test for independence 
with Yates continuity correction was not significant for percent clinically impaired (χ2 (1, n=80) = 
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.98, p = .32). In other words, survivors’ scores were statistically lower but not clinically 
impaired. 
A one-way between-groups analysis of covariance (ANCOVA) was conducted to compare 
the two groups on their Trial 5 z-scores, after controlling for Trial 1 z-scores. The independent 
variable was group (Survivors, Controls). The dependent variable consisted of z-scores on Trial 
5, administered after all consecutive presentations of the word list were complete. There was 
no statistically significant difference (F (1,77)=.33, p=.57) in Trial 5 z-scores for the two groups, 
after controlling for Trial 1 z-scores (see Figure 3.3). Similarly, a one-way between groups 
ANOVA showed that Learning Slope z-scores were not significantly different between the two 
groups (F (1,78)=1.66, p=.20).  
 
Figure 3.2 Performance on average within normal limits across 3 indices 
Note. *Indicates significant difference at p=.05. Error bars represent standard error. Means for 
recognition discriminability are estimated marginal means. LDFR = Long Delay Free Recall 
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Figure 3.3 ANCOVA results 
Note. Error bars represent standard error. Means shown are estimated marginal means. LDFR = 
Long Delay Free Recall 
3.6.2 2b Delayed free recall performance 
A one-way between groups ANOVA showed that there was no statistically significant 
difference (F (1,78)=3.55, p=.06) in LDFR z-scores for the two groups (see Table 3.4 & Figure 
3.2). However, on average, survivors did show a trend for scores that were lower than controls. 
The actual difference in mean scores between the groups was a small-medium effect size of .04, 
calculated using partial η2. Furthermore, the performance of 7 survivors (22%) and 6 controls 
(13%) was in the clinically impaired range (i.e. z≤ -1.5). A Pearson chi-square test for 
independence with Yates continuity correction was not significant for percent clinically 
impaired (χ2 (1, n=80) = .65, p = .42). In other words, survivors’ scores showed a trend for being 
significantly lower but were not clinically impaired. 
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A one-way between-groups ANCOVA was conducted to compare the two groups on 
their LDFR z-scores, after controlling for Trial 5 z-scores. The independent variable was group 
(Survivors, Controls). The dependent variable consisted of z-scores on LDFR, administered after 
a 20 minute delay. There was no statistically significant difference (F (1,77)=.47, p=.50) in LDFR 
z-scores for the two groups, after controlling for Trial 5 z-scores (see Figure 3.3). 
A mixed between-within subjects ANOVA was conducted to assess the impact of group 
(Survivors, Controls) on participants’ recall performance, across the time delay (Trial 5, LDFR). 
There was no significant interaction between group and time (F (1,78)=.77, p=.38). In other 
words, the change in number of words from Trial 5 to LDFR was the same for both groups.  
3.6.3 2c Recognition Performance 
The assumption of normality was violated for each of the two groups. As mentioned 
before, transforming the variable did not help. However, ANOVA is robust to this violation if the 
sample sizes are relatively equal and there are no outliers. Given that our sample meets these 
criteria, we proceeded with the analysis despite the assumption violation. Participants’ 
education level was used as a covariate in this analysis because it was significantly correlated 
(r=.33, p<.001) with Recognition Discriminability. Age at exam was also significantly correlated 
(r= -.24, p=.03) with Recognition Discriminability but was not used as a covariate, because it 
was also significantly correlated with education (r=.26, p=.02).  
After adjusting for education, there was no statistically significant difference (F 
(1,77)=1.30, p=.25) in Recognition Discriminability z scores for the two groups (see Table 3.4 & 
Figure 3.2). The actual difference in mean scores between the groups was a small effect size of 
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.02, calculated using η2, with survivors scoring lower. Furthermore, the performance of 6 
survivors (19%) and 6 controls (13%) was in the clinically impaired range (i.e. z≤ -1.5). A Pearson 
chi-square test for independence with Yates continuity correction was not significant for 
percent clinically impaired (χ2 (1, n=80) = .20, p = .66). 
A one-way between-groups ANCOVA was conducted to compare the two groups on 
their Recognition Discriminability z-scores, after controlling for LDFR z-scores. The independent 
variable was group (Survivors, Controls). The dependent variable consisted of z-scores on 
Recognition Discriminability, administered immediately after the LDFR trial was completed. 
There was no statistically significant difference (F (1,77)=.12, p=.73) in Recognition 
Discriminability z-scores for the two groups, after controlling for LDFR z-scores. 
3.7 Aim 3   
The associations between hippocampal volume, putamen volume (control structure), 
verbal memory indices (as measured by the CVLT-II), and fine motor skill (as measured by 
Grooved Pegboard), were investigated using Pearson product moment correlation coefficient. 
We used one-tailed significance values as we did not expect to find negative associations. 
Preliminary analyses were performed to ensure no violation of the assumptions of normality, 
linearity, and homoscedasticity. As mentioned before, the assumption of normality was 
violated for the Recognition Discriminability variable but we were unable to correct for this 
violation. All other assumptions were acceptable. 
We examined correlations between volume and verbal memory outcomes in the group 
of survivors alone (separately from controls). We did this because in neurologically intact adults 
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the “bigger is better” account of regional structure-function associations is considered too 
simplistic by some researchers (see Van Petten et al., 2004). There was a significant positive 
correlation (r=.34, n=32, p=.03) between hippocampal volume and LDFR of medium effect size. 
Higher hippocampal volume was associated with higher LDFR. The correlations of hippocampal 
volume with all other CVLT-II indices were not significant (see Table 3.5). Likewise, for the group 
of controls there were no significant correlations. 
Furthermore, to increase confidence that the aforementioned findings were related 
specifically to the hippocampus, we conducted correlation analyses with a control structure and 
control task: putamen and fine motor skill. None of the correlations of putamen volume and 
CVLT-II verbal memory indices were significant (see Table 3.5). Likewise, for the hippocampus 
the correlation with fine motor skill was not significant.  
Table 3.5 Associations between brain structure volumes and cognitive tasks 
 1 2 3 4 5 6 
1. Hippocampal Volume 1 .72* .25 .34* .22 .25 
2. Putamen Volume -- 1 .13 .13 .14 .13 
3. Trials 1-5 Total T score  -- -- 1 .82* .64* -.03 
4. Long Delay Free Recall z-score -- -- -- 1 .73* -.12 
5. Recognition z-score  -- -- -- -- 1 -.23 
6. Grooved Pegboard z-score -- -- -- -- -- 1 
Note. *Significant at p=.05 (one-tailed) 
4. DISCUSSION 
4.1 Interpretation of Findings for Aims 1, 2, and 3 
The purpose of this study was to examine hippocampus size and verbal memory 
performance in adult survivors of pediatric brain tumor, as well as possible associations of 
verbal memory with hippocampal volume. We confirmed the prediction that survivors who had 
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been diagnosed with a brain tumor at an average age of 8 years had significantly lower 
hippocampus volumes than neurotypical controls. Thus, even an average of 17 years after 
diagnosis disruption to a maturing brain was detectable. One study had observed declines in 
hippocampal volume until 2 years post-diagnosis (Nagel, Palmer, Reddick, et al., 2004). 
Together with current findings, this suggests that declines in the early years are not fully 
compensated for in later life for young adult survivors.    
 It should be noted that even though hippocampal volume was significantly lower for 
survivors a similar pattern was also observed for the control structure, the putamen. In fact, the 
effect size for difference in putamen volume was larger than that of hippocampal volume. 
There could be several reasons for this finding. One hypothesis is that the hippocampus is not 
specifically vulnerable despite its purportedly higher metabolic needs and disruption to brain 
development for survivors is more global in nature. This finding also highlights the importance 
of using control structures in neuropsychological studies of brain tumor survivors. It indicates 
that claims about structure-function relations, made by other research studies, need to be 
interpreted with caution. If structure-function associations are not supported by control region 
data, damage to the region of interest may not be local and could depict global brain changes. 
Although no existing research has tested verbal memory profiles in long-term (>5 years 
since diagnosis) adult survivors of pediatric brain tumor, short-term childhood and some adult 
brain tumor literature suggests memory difficulties. With regard to immediate free recall and 
learning characteristics we predicted lower immediate free recall compared to controls, lower 
auditory attention, and an intact learning slope. We confirmed that immediate free recall 
performance (Trials 1-5 T score) in survivors was significantly lower than controls. However, as 
40 
 
 
immediate free recall is a global measure of performance on the initial learning trials we 
analyzed the participants’ learning characteristics further in order to interpret these low 
immediate free recall scores. This revealed that when controlling for auditory attention (Trial 1 
z-score), the level of verbal information learned and recalled on the final trial (Trial 5 z-score) 
after repeated presentation of the word list was comparable for the survivor and control 
groups. This indicates that auditory attention problems could be contributing to their lower 
immediate free recall and confirms our prediction. Furthermore, we confirmed that the rate of 
new learning, i.e. average number of new words per trial per trial (Learning Slope), of survivors 
paralleled that of the controls although their overall level of immediate free recall was lower 
than controls.  
   With regard to delayed free recall and retention we predicted lowered delayed recall 
and lowered retention compared to controls. We confirmed that delayed free recall (LDFR) 
showed a trend for being significantly lower in the survivors group. However, when controlling 
for initial level of verbal material learned (Trial 5 z-score), the level of verbal information 
recalled after the delay period (LDFR z-score) was comparable for the survivor and control 
groups. This suggests that the initially lower number of words learned could be contributing to 
their lower delayed free recall and our prediction about problems with retention was refuted.  
Intact retention was further supported by the finding that the change in number of words from 
Trial 5 to LDFR was not significantly different for the two groups.  
Furthermore, counter to predictions, delayed recognition performance of the survivors 
was comparable to controls indicating that an encoding deficit profile (impairment at the level 
of recall and recognition) was not supported by the data in this group of adult survivors of 
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childhood brain tumor. In light of intact recognition, the pattern of similar rates of learning for 
the two groups but lower overall level of immediate and delayed free recall could point to mild 
retrieval problems. 
Moreover, it should be noted that 78% of survivors in our sample were performing 
within normal limits on delayed free recall (only 7/32 had impaired LDFR; z<-1.5). This suggests 
that that the despite initial difficulties with auditory attention and lowered overall level of 
immediate learning and free recall the verbal memory systems of these survivors are not 
impaired even though they may not be functioning at the same level as their neurotypical 
peers.  
Extant research, primarily in dementia and adult brain tumor survivors, shows that 
hippocampal abnormalities in adults should be predictive of impairments on both recall and 
recognition (encoding deficit profile). Many studies in patient populations as varied as 
Alzheimer’s disease (Libon, Bogdanoff, Cloud, Skalina, Giovannetti, Gitlin, & Bonavita, 1998), 
ischemic vascular dementia (Libon, Bogdanoff, Cloud, Skalina, Giovannetti, Gitlin, & Bonavita, 
1998), adults with temporal lobe epilepsy with adolescent onset (Reminger, Kaszniak, Labiner, 
et al., 2004),  combat veterans with and without PTSD (Tischler, Brand, Stavitsky et al., 2006), 
elderly women (Ystad, Lundervold, Wehling et al., 2009), and adolescents with a history of 
prematurity (Gimenez, Junque, Narberhaus, Caldu, Salgado-Pineda, Bargallo, Segarra, & Botet, 
2004),  have established a link between hippocampal volume and verbal memory. Moreover, 
some of these studies used the CVLT-II to measure verbal memory performance. However, the 
specific relationship between hippocampal volume and memory functioning is not well 
established among developing children.  
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The results of our study showed that the size of the hippocampus was significantly 
associated with delayed recall, for a group of adult survivors whose brains were still developing 
at the time of diagnosis and treatment during childhood.  We did not find hippocampus size to 
be linked to any of the other verbal memory indices, even recognition and learning slope, used 
in the current study. One potential explanation for why the brain structure – cognitive outcome 
relations in our sample are slightly different from the existing literature is that brain tumor 
diagnosis and treatment occurred during childhood, when the hippocampus was still 
developing. Another possible explanation for the lack of an association between hippocampal 
volume and recognition is that memory performance for our survivor was on average within 
normal limits across all three verbal memory indices. The severity of verbal memory problems 
in our sample is mild compared to the other aforementioned populations studied with regard 
to hippocampus size and memory.  
Nonetheless, we were able to demonstrate that survivors do have a smaller 
hippocampus size even though their verbal memory difficulties are mild and likely attributable 
to initial auditory attention and retrieval inefficiencies. Moreover, our confidence in the 
specificity of the relationship between the hippocampus and delayed free recall is increased by 
two other findings: (1) there was an absence of significant correlations between putamen 
volume and delayed free recall, despite lower putamen volume in survivors (2) the correlation 
between hippocampal volume and performance on a fine motor task was not significant.  
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4.2 Treatment Variables 
We explored the role of radiation therapy because it has been well linked to difficulties 
in cognitive performance for CNS and non-CNS cancer patients (Ellenberg, Liu, Gioia, et al., 
2009; Kadan-Lottick, Zeltzer, Liu et al., 2010; Temming & Jenney, 2010; Winqvist, Vainionpaa, 
Kokkonen, & Lanning, 2001). Given that 59% of the survivors in our sample had received 
radiation therapy we examined effect sizes for differences between each of the three groups 
(survivors with radiation, survivors with no radiation, controls). As expected, we found the 
strongest effect sizes when comparing survivors with radiation to controls across all of our 
dependent variables (see Table 4.2). When comparing survivors with no radiation to controls 
the effect sizes were consistently lower across all of our dependent variables (see Table 4.2). 
Hippocampal volume and CVLT-II performance scores were always lowest for the radiation 
group and the highest for the control group, with the no radiation group scores always being in 
between the scores for the radiation and control groups. This pattern of findings is consistent 
with the original planned analyses of each of our aims and suggests that more pronounced 
deficits exist for those who have received radiation therapy.  
Furthermore, it has been theorized that radiation therapy may be impacting 
neurocognitive function through several neurobiological processes. Pathological processes in 
the hippocampus in animal models have been shown to be caused by irradiation (Nagel et al., 
2004; Ris, 2007). Therefore, we explored if the associations between hippocampal volume and 
verbal memory indices were stronger for survivors who had received radiation. We found a 
significant (p=.02) positive correlation between hippocampal volume and LDFR in the radiation 
group (n=19), with a large effect size (r=.49), but not for the no radiation group (p=.28). No 
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other significant correlations between hippocampal volume and verbal memory indices were 
found for the radiation group but effect sizes were consistently larger than those found when 
examining the survivor group as a whole. These findings are in line with research on radiation 
therapy. Again these findings speak to the important role of radiation in below-normal volumes 
being associated with cognitive deficits.  
Our sample of survivors was heterogeneous with regard to neurobiological and 
treatment variables, such as time since diagnosis, age at diagnosis, presence of seizure disorder, 
chemotherapy, presence of hydrocephalus, and hormone deficiency. All of these variables have 
been shown to negatively impact cognitive outcomes in research studies with other 
populations. In addition, the 59% of survivors in our sample who had received radiation therapy 
had, on average, the lowest hippocampal volume. Therefore, we explored the overlap of 
radiation with these other variables. A look at Table 4.1 shows that many of the survivors who 
received radiation therapy also received chemotherapy and had a diagnosis of hormone 
deficiency, whereas the ones that did not receive radiation therapy generally did not receive 
chemotherapy or have hormone deficiency. These exploratory findings raise an important 
question about the relative contribution of various factors that contribute to hippocampal 
development during childhood and ultimately to total hippocampal volume in adulthood. They 
also raise the question of whether it is diagnostic and treatment complexity that disrupts 
hippocampal and memory development, rather than any single variable (e.g. radiation therapy). 
Capturing diagnostic and treatment complexity would involve quantifying the influence of 
tumor and treatment-related risk factors by using a measure such as the Neurological Predictor 
Scale (NPS) (see Micklewright, King, Morris, Krawiecki, 2008). Future research studies, with a 
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higher number of adult survivors of pediatric brain tumor in the no radiation group would be 
better positioned to answer these questions. They could examine the relative contribution of 
each of these variables to hippocampal volume using a technique such as multiple regression.  
Table 4.1 Overlap of radiation therapy with other neurobiological variables 
Diagnostic & Treatment Variables Radiation (n=19) No Radiation (n=13) 
Years post diagnosis (mean ± SD) 
 Range 
16.60 ± 5.87 
5 - 28 
17.69 ± 6.60 
7 - 27 
Age at diagnosis (mean ± SD) 
 Range 
7.95 ± 4.60  
1 - 19 
7.69 ± 5.09 
2 - 17 
Chemotherapy (n, %) 13 (68%) 1 (8%) 
Hydrocephalus (n, %) 8 (42%) 6 (46%) 
Seizure disorder (n, %) 4 (21%) 4 (31%) 
Hormone deficiency (n, %) 13 (68%) 3 (23%) 
Table 4.2 Effect sizes for group comparisons 
 
Radiation (n=19) 
(Mean±SD) 
No Radiation (n=13) 
(Mean±SD) 
Controls (n=48)  
(Mean±SD) 
d 
Hippocampal Volume 
 
7212.4±922.9 7702.1±853.3  -.55 
 7212.4±922.9  7888.6±833.9 -.79 
  7702.1±853.3 7888.6±833.9 -.22 
CVLT-II Trials 1-5 Total 43.84±12.86 51.31±8.34  -.66 
 43.84±12.86  52.21±11.08 -.72 
  51.31±8.34 52.21±11.08 -.09 
CVLT-II LDFR -.79±1.4 -.19±.93  -.49 
 -.79±1.4  -.05±1.08 -.43 
  -.19±.93 -.05±1.08 -.13 
CVLT-II Recognition -.47±1.15 0±.87  -.45 
 -.47±1.15  .08±.97 -.54 
  0±.87 .08±.97 -.08 
4.3 Limitations 
As participants for our study were recruited through large mailings inviting individuals to 
call to participate, selection bias must be considered. It is possible that the group of long-term 
survivors who participated chose to take part because cognitive problems were salient for this 
group. Alternatively, it may be that survivors with fewer cognitive concerns were more able to 
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participate. Given the large proportion of survivors who performed within normal limits, it is 
possible that our sample is higher functioning. Therefore, all interpretations and clinical 
recommendations that have emerged should be considered in those contexts. Furthermore, as 
we studied pre-existing naturally occurring groups – survivors of childhood brain tumors and 
healthy controls – this posed selection-related threats to validity. Therefore, causal conclusions 
from the findings cannot be made.  
The variable of Recognition Discriminability posed a problem for data analyses because 
the assumption of normality was violated and transforming the data did not aid with 
normalizing the distribution. Further exploratory analyses evidence consistent violations with 
Recognition Discriminability raw scores, Recognition Hits raw and z scores, and Recognition 
False Positive raw and z scores. Violation of this key assumption could have impacted our ability 
to detect true differences and associations with regard to this variable. Thus, all interpretations 
about the recognition performance of this sample should be nested in this context. 
Moreover, given problems with the indices, we explored Recognition Hits and 
Recognition False Positives raw and z-scores further and no significant differences were found 
between survivors and controls for any of the indices. Also, most of these indices were not 
correlated significantly with hippocampal volume, except False Positives raw and z-scores (r= -
.37, p=.02, n=32). This suggests that smaller hippocampal volume is related with higher false 
positives. Thus, the association between Recognition False Positive scores and hippocampal 
volume may be worth further examination in future studies. A previous study based on a larger 
sample from the existing data, a subset of which was used in our study, also found significantly 
higher number of False Positives in survivors compared to controls (Kohl, King, Morris, & 
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Krawiecki, 2011). None of the recognition indices were significantly correlated with putamen 
volume. 
Another limitation is our study’s inability to conduct MRI scans on individuals with 
certain types of metal in their skull or body and/or certain medical devices implanted at the 
time of surgery (e.g. shunts which create artefact or pose a safety risk). While most present day 
neurological devices are MRI-safe, exact specifications on surgery date, type of device, 
manufacturer name, and serial number are often essential in order to determine safety. These 
devices, when deemed unsafe for MRI, prevented us from gathering neuroimaging data. We 
were also unable to gather neuroimaging data in the absence of sufficient information about 
implanted devices. Therefore, survivors without such devices, who were scanned, may 
represent a “better outcome” group. It is possible, therefore, that findings may not generalize 
to survivors with greater neurological complications.  
4.4 Strengths and Innovation 
Our study has laid some of the foundation for understanding the nature of verbal 
memory function in adult survivors of childhood brain tumor. This foundation will continue to 
be a strength while cure rates for childhood brain tumors continue to be maintained and 
improved. As findings from our study have demonstrated an association of a specific neural 
substrate (hippocampus) with a specific type of neurocognitive function (verbal memory) and 
as more data on verbal memory in long-term survivors emerge, they will help clinicians make 
recommendations for neurocognitive rehabilitation that are grounded in neuropsychological 
research. Moreover, as most research with survivors takes place in the first decade following 
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treatment these studies lack the ability to address the extent of deficits that persist in the long-
term. Our study has allowed a long-term outlook for future development (i.e. 5-28 years post-
diagnosis, mean=17.04, median=17.05) in children treated for brain tumors. It has also allowed 
us to characterize memory deficits in the context of neurobiological structures that support 
these memory functions. While biomedical science has taken on the task of increasing survival, 
behavioural science needs to take on the task of improving the quality of survival. Framed in a 
broader context, our study is one of many crucial steps in improving the quality of survival for 
adult survivors of childhood brain tumor. 
Moreover, volumetric analysis of the hippocampus in adult survivors has helped us see 
that the hippocampus is smaller for survivors than controls and thus its development was likely 
disrupted in childhood. The nature of our study sample – brain insult during childhood and 
brain imaging in adulthood – has also made it possible to build knowledge from a 
developmental perspective. The volumetric analysis conducted in the current study have added 
to the extant literature by showing that declines in hippocampal volume reported during 
childhood CNS tumors are not ultimately compensated for by return to normal growth in later 
life. 
4.5 Future Directions 
Firstly, a functional MRI study (Fernandez, Weyerts, Schrader-Botsche et al., 1998) with 
healthy adults has shown that the posterior part of the hippocampus is engaged in verbal 
encoding when performing a word list learning task. Thus, it will be interesting for future 
research to manually delineate the posterior region of the hippocampus in brain tumor 
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survivors and examine whether the volume of this region yields stronger associations with 
verbal memory. 
Secondly, left hippocampal volume may be more sensitive to verbal memory. With 
regard to verbal memory function, it has been reported by several previous studies that there is 
greater left medial temporal lobe involvement (de Toledo-Morrell, Dickerson, Sullivan, et al., 
2000; Milner, 1971). Also, in a study of hemispheric specialization in the human medial 
temporal lobe, sensitivity of the left hippocampus to verbal material has been shown (Kelley, 
Meizin, McDermott, et al., 1998). In regions within or near the hippocampal formation word-
encoding, face-encoding, and object-encoding task all produced significant activations but in 
left medial temporal regions only word-encoding produced significantly greater left than right 
activation. In another study of elderly women, CVLT-II long delay free recall values were largely 
predicted by left hippocampal volume (Ystad, Lundervold, Wehling, et al., 2009). Given that our 
study used left and right hippocampus composite volumes, we may have reduced sensitivity the 
hippocampal volume – verbal memory associations. Therefore, it will be important to 
investigate potential lateralization of hippocampal function in brain tumor survivors using left 
and right volumes separately with material-specific memory tasks.   
Third, from a developmental perspective, age at diagnosis holds promise in terms of 
predicting verbal memory abilities in adult survivors of childhood brain tumor. Some 
researchers have noted that a younger age at diagnosis predicts poorer neuropsychological 
outcomes (Ellenberg, McComb, Siegel, & Stowe, 1987; Reimers, Ehrenfels, Mortensen et al., 
2003; Sands, Kellie, Davidow, Diez, Villablanca, & Weiner, 2001). Given the role development 
may play in the association of hippocampal volume and memory, it will be important for future 
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studies to examine more fully the role of age at diagnosis and time since diagnosis in explaining 
associations between hippocampal volume and memory performance. 
5. SUMMARY 
Our findings have provided us with a long-term outlook for hippocampal and memory 
development in children treated for brain tumors. Mainly, we know that disruption to a 
developing brain is associated with lower hippocampal and putamen volume on average 17 
years after diagnosis. This indicates that survivors, whose brain development has likely been 
disrupted due to tumor or treatment related factors, do not have volumes comparable to 
controls in later life.  Furthermore, we know that even though insults to a developing memory 
system may have occurred only during childhood, there are specific verbal memory weaknesses 
that are detectable long-term. These weaknesses likely continue to impact broader outcomes 
such as adaptive functioning and quality of life. These variables deserve continued attention for 
deciphering the complex impact of disease and treatment factors on developing brain structure 
and cognition.   
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